N Stallard, L Hampson, N Benda… - Statistics in …, 2020 - Taylor & Francis
The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized …
Recent FDA guidance on adaptive clinical trial designs defines bias as “a systematic tendency for the estimate of treatment effect to deviate from its true value”, and states that it is …
N Harel, T Routtenberg - IEEE Transactions on Signal …, 2020 - ieeexplore.ieee.org
Statistical inference of multiple parameters often involves a preliminary parameter selection stage. The selection stage has an impact on subsequent estimation, for example by …
Masihuddin, N Misra - Journal of Biopharmaceutical Statistics, 2024 - Taylor & Francis
ABSTRACT A common problem faced in clinical studies is that of estimating the effect of the most effective (eg the one having the largest mean) treatment among k (≥ 2) available …
Adaptive designs are commonly used in clinical and drug development studies for optimum utilization of available resources. In this article, we consider the problem of estimating the …
N Misra - arXiv preprint arXiv:2301.09124, 2023 - arxiv.org
Adaptive designs are commonly used in clinical and drug development studies for optimum utilization of available resources. In this article, we consider the problem of estimating the …
DS Robertson, B Choodari-Oskooei, M Dimairo… - arXiv preprint arXiv …, 2021 - arxiv.org
Recent FDA guidance on adaptive clinical trial designs defines bias as" a systematic tendency for the estimate of treatment effect to deviate from its true value", and states that it is …